ðŽéµã®è³ªåãšåç
質åïŒðŽç±³åœäžå ŽäŒæ¥ã®HilleVaxãéçºããŠããHIL-214ã¯ããããŠã€ã«ã¹äºäŸ¡GI.1/GII.4ãŠã€ã«ã¹æ§ç²åïŒVLPïŒã¯ã¯ãã³ã§ãããäž»åå
ç«ã«çšããããæ¥æ§èè
žç(AGE)ãåŒãèµ·ãããããŠã€ã«ã¹ã®äºé²ãç®çãšããŠããŸããä»æ¥ãå瀟ã¯5ã¶æã®ä¹³å
ã察象ãšããHIL-214ã®ç¬¬2çžèšåºè©ŠéšããäžçšåºŠãŸãã¯é床ã®æ¥æ§èè
žçäºä»¶ã®ããã€ãã®ãããŠã€ã«ã¹ã®äºé²ã«å¯ŸããŠæå¹ã§ããããšã蚌æã§ããªãã£ããšçºè¡šããŸãããHilleVaxã¯ã第2次éžæå åäžã®èšåºçå©çã芳å¯ããŠããŸããã§ããã
ããªãã¯ããã®å€±æããèšåºè©ŠéšãäŒç€Ÿã«äžãã圱é¿ãã©ã®ããã«è©äŸ¡ããŸããïŒäŒç€Ÿã¯ä»ã®åéã§ãã®æè¡ãã©ãããã©ãŒã ãå©çšããŠæåããå¯èœæ§ããããŸããïŒå¯èœæ§ãããå Žåãã©ã®ãããªé åã§å¯èœæ§ããããïŒçç±ã¯äœã§ããïŒãŸããHIL-214ã«é¢ããŠãäŒç€Ÿã¯ä»ã®å¹æãåŸãããšãã§ããŸããïŒ
ããªãã¯ããã®å€±æããèšåºè©ŠéšãäŒç€Ÿã«äžãã圱é¿ãã©ã®ããã«è©äŸ¡ããŸããïŒäŒç€Ÿã¯ä»ã®åéã§ãã®æè¡ãã©ãããã©ãŒã ãå©çšããŠæåããå¯èœæ§ããããŸããïŒå¯èœæ§ãããå Žåãã©ã®ãããªé åã§å¯èœæ§ããããïŒçç±ã¯äœã§ããïŒãŸããHIL-214ã«é¢ããŠãäŒç€Ÿã¯ä»ã®å¹æãåŸãããšãã§ããŸããïŒ
çãïŒâHilleVaxã¯ãHIL-214ã®ç¬¬2çžèšåºè©Šéšã§ããããŠã€ã«ã¹ã«ããäžçšåºŠãŸãã¯é床ã®æ¥æ§èè
žçïŒAGEïŒäºä»¶ã«å¯Ÿããã¯ã¯ãã³ã®æå¹æ§ã蚌æã§ããŸããã§ããããã®ãããªå€±æã¯ã以äžã®åœ±é¿ãšå¯èœæ§ããããããããããŸããïŒ
ðºåœ±é¿
1. æ ªäŸ¡ã®å€åãä»æ¥ããã®äŸ¡æ Œã¯80ïŒ ä»¥äžäžèœããŠããŸãã
2. ç 究éçºãžã®æè³ãšé²è¡ç¶æ³ïŒå€±æããè©Šéšã¯ãã¯ã¯ãã³ã®ç 究éçºæŠç¥ã®åèšèšã調æŽãå¿ èŠã§ãããæéãšè³éã®æå ¥ãå¢ããå¯èœæ§ããããŸãã
3. åžå Žä¿¡é ŒåºŠïŒå€±æãåžå ŽãææºããŒãããŒã«å¯ŸããäŒæ¥ã®æè¡åãšç 究éçºèœåã«å¯Ÿããä¿¡é ŒåºŠã«åœ±é¿ãäžããå°æ¥ã®è³é調éãææºæ©äŒã«åœ±é¿ãäžããå¯èœæ§ããããŸãã
1. æ ªäŸ¡ã®å€åãä»æ¥ããã®äŸ¡æ Œã¯80ïŒ ä»¥äžäžèœããŠããŸãã
2. ç 究éçºãžã®æè³ãšé²è¡ç¶æ³ïŒå€±æããè©Šéšã¯ãã¯ã¯ãã³ã®ç 究éçºæŠç¥ã®åèšèšã調æŽãå¿ èŠã§ãããæéãšè³éã®æå ¥ãå¢ããå¯èœæ§ããããŸãã
3. åžå Žä¿¡é ŒåºŠïŒå€±æãåžå ŽãææºããŒãããŒã«å¯ŸããäŒæ¥ã®æè¡åãšç 究éçºèœåã«å¯Ÿããä¿¡é ŒåºŠã«åœ±é¿ãäžããå°æ¥ã®è³é調éãææºæ©äŒã«åœ±é¿ãäžããå¯èœæ§ããããŸãã
ðºæè¡ãã©ãããã©ãŒã ãå©çšããä»ã®æåã®å¯èœæ§
éç¶HIL-214åšé次枬詊äžæ²æååŸæåïŒäœHilleVaxä»ç¶å¯ä»¥åšä»¥äžæ¹é¢å©çšå ¶æè¡å¹³å°ååŸæåïŒ
éç¶HIL-214åšé次枬詊äžæ²æååŸæåïŒäœHilleVaxä»ç¶å¯ä»¥åšä»¥äžæ¹é¢å©çšå ¶æè¡å¹³å°ååŸæåïŒ
1. ã¯ã¯ãã³ã®æ¹è¯ãšæé©åïŒäŒç€Ÿã¯å€±æã®åå ãåæããã¯ã¯ãã³ã®é
åãæäžæ¹æ³ãæ¹åããããšã§ããããŠã€ã«ã¹ã«å¯Ÿããå¹æãé«ããããšãã§ããŸãã
2. ä»ã®ãŠã€ã«ã¹ã«å¯Ÿããã¯ã¯ãã³ã®éçºïŒHilleVaxã®æè¡ãã©ãããã©ãŒã ã¯ãå¹ åºãå¿çšå¯èœæ§ãæã¡ããã¿ãŠã€ã«ã¹ãã¢ãããŠã€ã«ã¹ãªã©ä»ã®ãŠã€ã«ã¹ã«å¯Ÿããã¯ã¯ãã³ã®éçºã«äœ¿çšã§ããŸãã
3. **å ç«çæ³**ïŒäŒç€Ÿã®æè¡ãã©ãããã©ãŒã ã¯ã¯ã¯ãã³éçºã«ãšã©ãŸãããæ²»çã¯ã¯ãã³ãããå ç«çæ³ãªã©ä»ã®ã¿ã€ãã®å ç«çæ³ã®éçºã«ãå©çšã§ããå¯èœæ§ãããã
2. ä»ã®ãŠã€ã«ã¹ã«å¯Ÿããã¯ã¯ãã³ã®éçºïŒHilleVaxã®æè¡ãã©ãããã©ãŒã ã¯ãå¹ åºãå¿çšå¯èœæ§ãæã¡ããã¿ãŠã€ã«ã¹ãã¢ãããŠã€ã«ã¹ãªã©ä»ã®ãŠã€ã«ã¹ã«å¯Ÿããã¯ã¯ãã³ã®éçºã«äœ¿çšã§ããŸãã
3. **å ç«çæ³**ïŒäŒç€Ÿã®æè¡ãã©ãããã©ãŒã ã¯ã¯ã¯ãã³éçºã«ãšã©ãŸãããæ²»çã¯ã¯ãã³ãããå ç«çæ³ãªã©ä»ã®ã¿ã€ãã®å ç«çæ³ã®éçºã«ãå©çšã§ããå¯èœæ§ãããã
ðº HIL-214ããã®ä»ã®å¹æã§æåããå¯èœæ§
HIL-214ã¯äžç床ãŸãã¯é床ã®æ¥æ§èè žçã€ãã³ãã§ãæ確ãªå¹æã芳å¯ãããªãã£ãã«ããããããããŸã ä»ã®é åã§å¯èœæ§ãç§ããŠããã
HIL-214ã¯äžç床ãŸãã¯é床ã®æ¥æ§èè žçã€ãã³ãã§ãæ確ãªå¹æã芳å¯ãããªãã£ãã«ããããããããŸã ä»ã®é åã§å¯èœæ§ãç§ããŠããã
1. **軜床AGEã®äºé²**ïŒã¯ã¯ãã³ã¯è»œåºŠã®æ¥æ§èè
žçã®äºé²ã«äžå®ã®æå¹æ§ã瀺ãå¯èœæ§ããããããå
¬è¡è¡çäžã®æ矩ãæã€ã
2. **ç°ãªãã°ã«ãŒãã§ã®å¹æ**ïŒHIL-214ã¯ã幎霢局ãç°ãªãä»ã®ã°ã«ãŒããç¹å®ã®å¥åº·ç¶æ ãæã€äººã ã§ç°ãªãå¹æã瀺ãå¯èœæ§ãããã
3. **䜵çšçæ³**ïŒã¯ã¯ãã³ã¯ä»ã®æ²»çæ³ãšäœµçšããŠå šäœçãªäºé²å¹æãé«ããããšãã§ããå¯èœæ§ãããã
ðºçµè«
HilleVaxã®HIL-214ã¯ã¯ãã³ã®ç¬¬2çžèšåºè©Šéšã®å€±æã¯ã倱æåå ã®æ·±ãåæãšæ¹åãããã³ä»ã®ãŠã€ã«ã¹ãæ²»çåéã§ã®æ¡å€§å¿çšã«äŸåããŠãæè¡ãã©ãããã©ãŒã ãå©çšããŠã¯ã¯ãã³éçºããã³å ç«çæ³ã§æåãåããå¯èœæ§ãããã
2. **ç°ãªãã°ã«ãŒãã§ã®å¹æ**ïŒHIL-214ã¯ã幎霢局ãç°ãªãä»ã®ã°ã«ãŒããç¹å®ã®å¥åº·ç¶æ ãæã€äººã ã§ç°ãªãå¹æã瀺ãå¯èœæ§ãããã
3. **䜵çšçæ³**ïŒã¯ã¯ãã³ã¯ä»ã®æ²»çæ³ãšäœµçšããŠå šäœçãªäºé²å¹æãé«ããããšãã§ããå¯èœæ§ãããã
ðºçµè«
HilleVaxã®HIL-214ã¯ã¯ãã³ã®ç¬¬2çžèšåºè©Šéšã®å€±æã¯ã倱æåå ã®æ·±ãåæãšæ¹åãããã³ä»ã®ãŠã€ã«ã¹ãæ²»çåéã§ã®æ¡å€§å¿çšã«äŸåããŠãæè¡ãã©ãããã©ãŒã ãå©çšããŠã¯ã¯ãã³éçºããã³å ç«çæ³ã§æåãåããå¯èœæ§ãããã
å
責äºé
ïŒãã®ã³ãã¥ããã£ã¯ãMoomoo Technologies Inc.ãæè²ç®çã§ã®ã¿æäŸãããã®ã§ãã
ããã«è©³ããæ
å ±
ã³ã¡ã³ã
ãµã€ã³ã€ã³ã³ã¡ã³ãããã
åçŸæ·±è ã¹ã¬äž» :
ããªãŒã¶ãŒã®2çªç®ã®ä¿ææ ªããã®çç©å»åŠæ¥çš®ã®å°éæè³æ©é¢ãèé£ç³»ã§ããããïŒ æè³ã®ãªã¹ã¯ã³ã³ãããŒã«ã«å¯ŸããŠããã®æ¥çã®å°éæè³æ©é¢ã¯ãåäžã®è¬å€ã®èšåºè©Šéšã«å€§éæè³ããããšãæŸçœ®ããã®ã§ããããïŒ å ããŠãå瀟ã®æ ªåŒä¿æã¯2021幎第4ååæ以éäžè²«ããŠå¢å ããŠããã240äžæ ªãã1,000äžæ ªä»¥äžã«å¢å ããŠããŸãïŒ å
éšäººå¡ã®ããžã·ã§ã³ã®å€åãèŠãŠã¿ãŸãããïŒ
å瀟ã¯äžäŸ¡ãããŠã€ã«ã¹åè£ã¯ã¯ãã³ HIL-216 ãéçºäžã§ããŸã æ©æ段éã«ãããŸãã
è¶
é·æã®ãã³ãã£ãŒã®å°å£æ ªã§ããŒããã©ãªãªãæ§ç¯äžïŒ![fire ð¥](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f525.png)
åçŸæ·±è ã¹ã¬äž» : ãèŠãã®ã¯ã¯ãã³ãŸãã¯è¬ãã幎霢局ã«ãã£ãŠãã®å¹æã«å€§ããªéããããäŸãæããããšãã§ããŸããïŒ
以äžã¯ã幎霢局ã§å¹æã«å€§ããªéããããããã€ãã®ã¯ã¯ãã³ãŸãã¯è¬ã®äŸã§ãã
ã¯ã¯ãã³
è¬
1. **ã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³**ïŒ
- **åäŸ**ïŒå®ææ¥çš®ã«ãã£ãŠãåäŸã®ã€ã³ãã«ãšã³ã¶é¢é£ã®å ¥é¢ããã³å䜵çãåçã«æžå°ãããããšãã§ããŸãã
- **é«éœ¢è **ïŒå ç«ã·ã¹ãã ã®æ©èœäœäžã«ãããé«éœ¢è ã¯ã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã«å¯Ÿããåå¿ãéåžžããã匱ããæå¹æ§ãäœããªããŸãããäŸç¶ãšããŠéç床ããã³å䜵çãæžå°ãããããšãã§ããŸãã
2. **çŸæ¥å³ã¯ã¯ãã³ïŒTdapïŒ**ïŒ
- **乳幌å **ïŒçŸæ¥å³ã乳幌å ã«å€ãèŠããããããçŸæ¥å³ã¯ã¯ãã³ã¯ä¹³å¹Œå ã«ãšã£ãŠéåžžã«éèŠã§ãã
ã - **ææ¥æããã³æ人**ïŒææ¥æããã³æ人ã«ãä¿è·äœçšãããããä¿è·åãäœããææåŸã®çç¶ã軜床ã§ããã
3. **æ°Žçã¯ã¯ãã³**ïŒ
- **åäŸ**ïŒæ°Žçã¯ã¯ãã³ã¯ãåäŸã®äžã§éåžžã«å¹æçã§ãããã»ãšãã©ã®æ°Žçã±ãŒã¹ãäºé²ã§ããŸãã
- **æ人**ïŒã¯ã¯ãã³æªæ¥çš®ããã³æ°Žçæªçœ¹æ£ã®æ人ã«å¯ŸããŠãæå¹ã§ããããå ç«ã·ã¹ãã ã®åå¿ãç°ãªããããå¹æã¯åäŸæã«æ¥çš®ããå¹æãããå£ãå¯èœæ§ãããã
1. **ã¢ã¹ããªã³**ïŒ
- **æ人**ïŒã¢ã¹ããªã³ã¯ãäžå¹Žããã³é«éœ¢è ã«ãšã£ãŠå¿è¡ç®¡çŸæ£ã®äºé²ïŒå¿èçºäœããã³è³åäžãªã©ïŒã«å¹æçã§ãããç¹ã«ãªã¹ã¯ãé«ãæ£è ã«é©ããŠããŸãã
- **乳幌å **ïŒã¢ã¹ããªã³ã䜿çšãããšé節ãªå¯äœçšïŒã¬ã€ã·çå矀ãªã©ïŒãçããå¯èœæ§ãããããã乳幌å ã«ã¯äœ¿çšããªãã§ãã ããã
2. **ã¹ã¿ãã³å€**ïŒ
- **æ人**ïŒã¹ã¿ãã³å€ã¯ãã³ã¬ã¹ãããŒã«ãäœäžãããããã«åºã䜿çšãããäžå¹Žããã³é«éœ¢æ£è ã«ç¹ã«å¹æçã§ãã
- **乳幌å **ïŒäžè¬çã«ä¹³å¹Œå ãžã®äœ¿çšã¯æšå¥šãããŠããããç¹å®ã®çŸæ£ïŒå®¶ææ§é«ã³ã¬ã¹ãããŒã«è¡çãªã©ïŒãããå Žåãé€ããé·æçãªå®å šæ§ããã³æå¹æ§ã¯ãŸã ç 究ãå¿ èŠã§ãã
3. **ã¢ãžã¹ããã€ã·ã³**ïŒ
- **æ人**ïŒã¢ãžã¹ããã€ã·ã³ã¯ãæ人ã®çŽ°èææïŒèºçããã³æ°ç®¡æ¯çãªã©ïŒã®æ²»çã«éåžžã«å¹æçã§ãã
- **乳幌å **ïŒä¹³å¹Œå ã«ã䜿çšãããŸãããè³ã®ææçãªã©ç¹å®ã®çŸæ£ãæ²»çããå Žåãå¹æãä»ã®æçç©è³ªãšåçãŸãã¯ãã以äžã§ããå¯èœæ§ããããå¯äœçšãç°ãªãå ŽåããããŸãã
ãããã®äŸãããç°ãªã幎霢局ã®æ£è ãã¯ã¯ãã³ããã³è¬ã«å¯Ÿããåå¿ã«ã¯å€§ããªéããããå¯èœæ§ããããããæ²»çèšç»ãçå®ããéã«ã¯ãæ£è ã®å¹Žéœ¢ããã³ç¹å®ã®å¥åº·ç¶æ ãèæ ®ããå¿ èŠãããããšã瀺ãããŠããŸãã
åçŸæ·±è ã¹ã¬äž» :
HilleVaxã®æè¡ãã©ãããã©ãŒã ã¯ãNorovirusã¯ã¯ãã³ã®éçºã«äž»èŠã«çŠç¹ãåœãŠãŠãããç¹ã«äž»èŠãªåè£ã¯ã¯ãã³ã§ããHIL-214ã«æ³šåããŠããŸããHilleVaxã¯ãæè¿ã®ã¯ã¯ãã³éçºã«ãããŠæ³šç®ãããŠããããŠã€ã«ã¹æ§ç²åïŒVirus-Like ParticlesãVLPïŒæè¡ã䜿çšããŠããŸãã以äžã¯ããã®æè¡ãã©ãããã©ãŒã ã®ç¹åŸŽãšãã®å©ç¹ããã³æ¬ ç¹ã«ã€ããŠã®èª¬æã§ãïŒ
### æè¡ãã©ãããã©ãŒã ç¹åŸŽ
1. **ãŠã€ã«ã¹æ§ç²åïŒVLPïŒ**ïŒHilleVaxã®æè¡ãã©ãããã©ãŒã ã¯VLPã䜿çšããŠããããŠã€ã«ã¹ã®æ§é ãæš¡å£ããŠããŸããããããã®ç²åã¯ãŠã€ã«ã¹ã®éºäŒåç©è³ªãå«ãŸããææã®ãªã¹ã¯ã¯ãããŸãããVLPã¯ãå®éã®ãŠã€ã«ã¹ææãšåæ§ã®åŒ·ãå ç«åå¿ãåŒãèµ·ããããšãã§ããŸãããå®éã®ãŠã€ã«ã¹ã®ãªã¹ã¯ã¯ãããŸããã
2. **å€äŸ¡ã¯ã¯ãã³**ïŒHIL-214ã¯ãNorovirusã®GI.1ãšGII.4ã®2ã€ã®äž»èŠãªã¹ãã¬ã€ã³ãå«ãäºäŸ¡ã®ã¯ã¯ãã³ã§ãããã®å€äŸ¡ã¯ã¯ãã³ã®èšèšã¯ãããåºç¯ãªä¿è·ãæäŸããããåºãç¯å²ã®Noroviruså€ç°æ ªãã«ããŒããããšãç®çãšããŠããŸãã
3. **éäžæ²»ç宀䜿çšã®ããã®ã³ã³ãããŒã«**ïŒãã®ãã©ãããã©ãŒã ã¯ãäžçäžã§æ¥æ§èè žçã®äž»èŠãªåå ã®1ã€ã§ãããæ¥æ§èè žçãåŒãèµ·ããNorovirusã«äž»ã«çŠç¹ãåœãŠãŠããŸãã
### å©ç¹
1. **匷åãªå ç«åæ§**ïŒVLPã¯ããŠã€ã«ã¹ã®æ§é ãå¹æçã«æš¡å£ãã匷åãªå ç«åå¿ãèªçºããããšãã§ããŸãããå®éã«ææãããªã¹ã¯ã¯ãããŸããã
2. **é«ãå®å šæ§**ïŒVLPã¯ããŠã€ã«ã¹ã®éºäŒåç©è³ªãå«ãŸãªããããè€è£œãææãåŒãèµ·ãããªã¹ã¯ãäœããã¯ã¯ãã³æ¥çš®åŸã®å®å šæ§ãªã¹ã¯ãäœæžããŸãã
3. **æœåšçãªåºç¯ãªäœ¿çš**ïŒVLPæè¡ã¯ãNorovirusã¯ã¯ãã³ã ãã§ãªãã人éããããŒããŠã€ã«ã¹ïŒHPVïŒãä¹åèçãŠã€ã«ã¹ïŒHBVïŒãªã©ã®ä»ã®ãŠã€ã«ã¹ã«ãé©çšã§ãããããã®åéã§ãæåãåããŠããŸãã
4. **å€äŸ¡ä¿è·**ïŒHIL-214ã¯ãå€æ°ã®ãŠã€ã«ã¹æ ªãå«ããããšã§ãããåºç¯ãªä¿è·ãæäŸããæ¥æ§èè žçãæžå°ãããããšãç®æããŠããŸãã
### æ¬ ç¹
1. **èšåºè©Šéšã®ãªã¹ã¯**ïŒæè¿ã®èšåºè©Šéšã®å€±æã¯ãåæç 究ã§æœåšåã瀺ããŠããã«ããããããã倧èŠæš¡ãªèšåºè©Šéšã§ã®æå¹æ§ã®æ€èšŒã«ã¯èª²é¡ããããããæåŸ ã«å¿ããããªãæå¹æ§ã®åé¡ã«çŽé¢ããå¯èœæ§ããããŸãã
2. **è€éãªçç£ããã»ã¹**ïŒVLPã®çç£ããã»ã¹ã¯è€éã§ãé«ã³ã¹ããªãã€ãªãã¯ãããžãŒè£œé ããã»ã¹ã«é¢ä¿ããŠããŸããããã¯ãã¯ã¯ãã³ã®è² æ å¯èœæ§ãšãµãã©ã€ãã§ãŒã³ç®¡çã«åœ±é¿ãäžããå¯èœæ§ããããŸãã
3. **å ç«æç¶æ§ã®äžç¢ºå®æ§**ïŒVLPã¯åŒ·åãªå ç«åå¿ãèªçºã§ããŸããããã®é·æã«ãããå ç«ä¿è·å¹æïŒæç¶æ§ïŒã¯ furtheræ€èšŒãå¿ èŠã§ãã
4. **ç°ãªã£ãæ ªã«å¯Ÿããé åæ§**ïŒNorovirusã¯éåžžã«å€ç°ããæ°ããå€ç°æ ªã¯æ¢åã®ã¯ã¯ãã³ã®ä¿è·ãåé¿ããå¯èœæ§ããããã¯ã¯ãã³ã®å®æçãªæŽæ°ãšåè©äŸ¡ãå¿ èŠã«ãªãå¯èœæ§ããããŸãã
### çµè«
HilleVaxã®æè¡ãã©ãããã©ãŒã ã¯ããŠã€ã«ã¹æ§ç²åæè¡ã«åºã¥ããŠãããé«ãå ç«åæ§ãšå®å šæ§ãåããŠããŸãããèšåºè©Šéšã®ãªã¹ã¯ãè€éãªçç£ããã»ã¹ãªã©ã®èª²é¡ã«çŽé¢ããŠããŸããHIL-214ã®æè¿ã®èšåºè©Šéšã®çµæãæåŸ ã«å¿ããããªãã£ãã«ãããããããHilleVaxã¯ãæè¡ãã©ãããã©ãŒã ãæ¹åãæ¡å€§ããããšã§ãä»ã®åéã§ãæåãåããå¯èœæ§ããããŸãã
åçŸæ·±è ã¹ã¬äž» : HilleVaxã¯ãæ人åãã®HIL-214ãšãã1ã€ã®ã¯ã¯ãã³åè£ã§ããHIL-216ã®éçºã®å¯èœæ§ãåŒãç¶ãè¿œæ±ããäºå®ã§ãã
åçŸæ·±è ã¹ã¬äž» :
ãããŠã€ã«ã¹ã¯ãã°ããŒãã«ãªäžé«æåŸåœå®¶ãè³æºãäžè¶³ããå°åã«ãããèè
žçã®äž»ãªåå ãšãªã£ãŠããŸããéçåããå¯èœæ§ãæãé«ã人ã
ã«ã¯ã幌å
ãé«éœ¢è
ãå
ç«åãäœäžããŠãã人ã
ãå«ãŸããŸãããããŠã€ã«ã¹ã¯é«ãææåãæã¡ãç°å¢æ¡ä»¶ã«é«ãèæ§ã瀺ãã人ãé£ç©ãæ±æãããè¡šé¢ãä»ããŠåºãããŸãããããŠã€ã«ã¹ã¯ãååãäžç¢ãçºç±ãè±æ°Žçç¶ãè
¹çãåŒãèµ·ãããå
¬è¡è¡çã«å€§ããªè² æ
ããããŠããŸããæ人ãšé«éœ¢å
ã®çç¶ã¯äŒŒãŠããŸããç£æ¥åãããåœã§ã¯å¹Œå
ã®æ¥æ§èè
žçïŒAGEïŒãæ»ã«è³ãããšã¯ãã£ãã«ãããŸããããçºå±éäžåœã§ã¯ããäžè¬çã§ããããã¯å¹Œå
ã®å
¥é¢åå ã«ãªãå¯èœæ§ããããŸãããçåŸ6ãæ以å
ã§ã¯å°ãªãåŸåããããŸããããã¯èç€äŒæãæ¯ä¹³äžã®æäœã®åœ±é¿ãããããã§ãããŸãããããŠã€ã«ã¹ã®ææã¯ãç
é¢ãåŠæ ¡ãä¿è²æããã®ä»ééçãªç°å¢ã«å€§ããªç€ŸäŒçã»çµæžç圱é¿ããããããŸãããã¿ãŠã€ã«ã¹ã®ã¯ã¯ãã³æ¥çš®èšç»ãæåããã«ã€ããŠã幌å
æã®ãã¿ãŠã€ã«ã¹ææã®è² æ
ã¯æžå°ããŠããŸããããããŠã€ã«ã¹ææã¯ããã®ä»å€ãã®åœã§AGEã®äž»èŠåå ãšèªèãããããã«ãªã£ãŠããŸãã
åçŸæ·±è ã¹ã¬äž» :![o â](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/2b55.png)
ãNESt-IN1è©Šéšãäž»èŠæå¹æ§ãšã³ããã€ã³ããæºãããªãã£ãããšã«å€±æããŠããŸããããšHilleVaxã®Chairmanå ŒCEOã§ããRob Hershberg MDãPhDã¯è¿°ã¹ãŠããŸãããHIL-214ã¯ä»¥åãæ人ã«ãããèšåºçãªå©çã瀺ããŠããŸããããNESt-IN1ã¯ãããŠã€ã«ã¹ã¯ã¯ãã³ã®åè£ãšããŠä¹³å¹Œå ã§å®æœãããæåã®æå¹æ§ç 究ã§ãã乳幌å èšå®ã§ã®æå¹æ§ã¯ããã®è©Šéšã§åºçŸããå€æ°ã®æ°èGII.4åã«åœ±é¿ãåããå¯èœæ§ããããšèããŠããŸããã
ãéåžžã«å³æ Œãªç 究ãå®æœããŠãããè©Šéšèª¿æ»å¡ãèšåºçŸå ŽãHilleVaxããŒã ã«å¿ããæè¬ããŠãããŸãããããŠããã®è©Šéšã«åå ããŠããã乳幌å ãšå®¶æã«æ·±ãæè¬ããŠããŸããããšHershbergå士ã¯è¿°ã¹ãŠããŸãã
NOR-211ã§ãããŠã€ã«ã¹ã«ããäžç床ãŸãã¯é床AGEã«å¯ŸããŠçµ±èšçã«ææãªæå¹æ§ã瀺ããæ人ã®20åçžåœã®ç¬¬2段éã®è©Šéšã®åŸã«ãNESt-IN1è©Šéšãå®æœãããŸãããå瀟ã¯ãHIL-214ã®ä¹³å¹Œå ã§ã®ãããªãéçºãäžæ¢ããæ人ã®HIL-214ãšHIL-216ïŒHilleVaxã®ç¬¬1匟ã®ã¯ã¯ãã³åè£ïŒã®éçºã®å¯èœæ§ãæ€èšããŠããŸãã